comparemela.com

Page 17 - Hoffmann News Today : Breaking News, Live Updates & Top Stories | Vimarsana

F Hoffmann-La Roche Ltd: FDA grants Priority Review to Roche s Lunsumio for people with relapsed or refractory follicular lymphoma

Lunsumio (mosunetuzumab) could be the first CD20xCD3 T-cell engaging bispecific antibody approved by the FDA for the treatment of any type of non-Hodgkin lymphoma Application is based on results from the

F Hoffmann-La Roche Ltd: Roche launches new BenchMark ULTRA PLUS system for cancer diagnostics enabling timely, targeted patient care

The BenchMark ULTRA PLUS tissue staining system, with optimised workflow, testing efficiency and environmentally sustainable features, enables pathologists to provide high-quality, time-critical results

F Hoffmann-La Roche Ltd: Roche launches the VENTANA DP 600 slide scanner for digital pathology, enhancing patient care with precision diagnostics

The VENTANA DP 600 is Roche's new, high-capacity slide scanner that creates high-resolution, digital images of stained tissue samples that help to diagnose cancer and determine a patient's treatment.Cancer

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.